Vanderbilt researchers are working to better design immune therapies that attack tumors without also attacking healthy normal tissue in patients.
https://news.vumc.org/2023/11/17/tumor-antigens-key-to-improving-cancer-immunotherapy-study/
![Tumor antigens key to improving cancer immunotherapy: study Tumor antigens key to improving cancer immunotherapy: study](/sites/default/files/drupalfiles/2023-02/VUMC-News_final.jpg)
Bill Snyder
304507
https://news.vumc.org/?p=304507
Unlocked